Agios Pharma (AGIO) PT Raised to $89 at Needham & Company
Needham & Company raised its price target on Agios Pharma (NASDAQ: AGIO) to $89.00 (from $86.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
